Product Details
SERETIDE
Fluticasone Propionate; Salmeterol (Salmeterol Xinafoate)125 mcg; 25 mcg
Inhalation powder
ROA
Inhalation, Oral
Applicant Name
Glaxo Smithkline Consumer Nigeria PLC
NRN
04-6850
Status
Active
Composition
ATC Code
R03AK06
Product Category
Drugs
Marketing Category
Prescription-only Medicine (POM)
Packsize
1 X 120 actuations
Product Description
25 RNW-PP-310050 SERETIDE 25MCG SALMETEROL/ 125MCG FLUTICASONE PROPIONATE Salmeterol xinafoate equivalent to 25 micrograms of salmeterol and 125 micrograms of fluticasone propionate Apr-50 Drugs Imported Products 1*120actuations POM 1 2/1/2023 GLAXOSMITHKLINE PHARMACEUTICAL NIGERIA LTD., INDUSTRIAL AVENUE ILUPEJU LAGOS 12711000 delphine.u.onyeaso@gsk.com GLAXO WELLCOME PRODUCTION, ZONE INDUSTRIELLE No 2, 23, RUE LAVOISIER 27000 EVREUSX FRANCE, France
Manufacturer Name
Glaxo Wellcome Production
Manufacturer Country
FRANCE
Approval Date
2023-05-25
Expiry Date
2028-05-24